Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Antonarakis ES, Piulats JM, Gross-Goupil M, Goh J, et al. Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study. J Clin Oncol 2019 Nov 27:JCO1901638. doi: 10.1200/JCO.19.01638.
PMID: 31774688


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016